Piscaglia F, Gaiani S, Gramantieri L, Zironi G, Siringo S, Bolondi L
Dipartimento di Medicina Interna e Gastroenterologia, Università di Bologna, Italy.
Am J Gastroenterol. 1998 Oct;93(10):1925-30. doi: 10.1111/j.1572-0241.1998.00474.x.
The increase of splanchnic blood flow volume in liver cirrhosis is attributed to decreased arterial resistance. The aim of this study was to noninvasively investigate superior mesenteric artery impedance in patients with chronic liver diseases and to assess its relationship with portal hemodynamics and with clinical parameters.
Superior mesenteric artery (SMA) pulsatility (SMA-PI) and resistance (SMA-RI) indices and portal vein flow parameters (velocity, volume, and congestion index) were measured by duplex-Doppler ultrasound in 14 patients with chronic hepatitis, in 73 cirrhotics, in 30 liver transplant recipients, and in 31 control subjects.
SMA-PI significantly differed among the five groups (p < 0.0001), being lower in cirrhotics (2.55+/-0.70) and transplanted patients (2.77+/-0.69) than in chronic hepatitis (3.28+/-0.57) and control subjects (3.42+/-0.92). SMA-PI was lower in ascitic cirrhosis (2.40+/-0.71) than in compensated cirrhosis (2.71+/-0.70) (p < 0.01) and in cirrhotics with large varices (2.30+/-0.67) than in those without varices (2.75+/-0.65) (p < 0.05). Moreover SMA-PI correlated with numeric Child-Pugh score (r=-0.28) and portal vein congestion index (r=-0.36).
Hyperdynamic splanchnic circulation, noninvasively assessed by a decrease of mesenteric artery impedance, occurs in cirrhosis since the early stage of the disease and tends to worsen in relation to liver failure and the severity of portal hypertension. Furthermore, the persistent SMA-PI decrease in transplant recipients suggests a consistent contribution to this circulatory alteration from a patent portosystemic collateral circulation.
肝硬化时内脏血流量增加归因于动脉阻力降低。本研究旨在无创性研究慢性肝病患者的肠系膜上动脉阻抗,并评估其与门静脉血流动力学及临床参数的关系。
采用双功多普勒超声测量14例慢性肝炎患者、73例肝硬化患者、30例肝移植受者及31例对照者的肠系膜上动脉搏动指数(SMA-PI)和阻力指数(SMA-RI)以及门静脉血流参数(速度、流量和充血指数)。
五组间SMA-PI有显著差异(p<0.0001),肝硬化患者(2.55±0.70)和肝移植患者(2.77±0.69)的SMA-PI低于慢性肝炎患者(3.28±0.57)和对照者(3.42±0.92)。腹水型肝硬化患者(2.40±0.71)的SMA-PI低于代偿期肝硬化患者(2.71±0.70)(p<0.01),有大静脉曲张的肝硬化患者(2.30±0.67)的SMA-PI低于无静脉曲张者(2.75±0.65)(p<0.05)。此外,SMA-PI与Child-Pugh数字评分(r=-0.28)及门静脉充血指数(r=-0.36)相关。
肝硬化患者自疾病早期即出现通过肠系膜动脉阻抗降低无创评估的高动力内脏循环,且随着肝衰竭和门静脉高压严重程度的增加而趋于恶化。此外,肝移植受者持续降低的SMA-PI提示门静脉侧支循环开放对这种循环改变有重要作用。